328
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

A Portfolio-Based Approach to Optimize Proof-of-Concept Clinical Trials

, , , , &
Pages 596-607 | Received 15 Aug 2010, Accepted 15 Feb 2011, Published online: 14 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jiandong Lu & Bin Dong. (2017) The Evaluation of Proof-of-Concept Trial Design for Compound Selection. Statistics in Biopharmaceutical Research 9:4, pages 315-320.
Read now

Articles from other publishers (3)

Rosalind J. Walley & Andrew P. Grieve. (2021) Optimising the trade‐off between type I and II error rates in the Bayesian context . Pharmaceutical Statistics 20:4, pages 710-720.
Crossref
Laurence Colin & Brian Smith. 2019. Statistical Methods in Biomarker and Early Clinical Development. Statistical Methods in Biomarker and Early Clinical Development 221 245 .
Roland Fisch, Ieuan Jones, Julie Jones, Jouni Kerman, Gerd Karl Rosenkranz & Heinz Schmidli. (2015) Bayesian Design of Proof-of-Concept Trials. Therapeutic Innovation & Regulatory Science 49:1, pages 155-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.